Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Sridhar Rao MD, PhD
Associate Professor
Department of Pediatrics
Division of Hematology and Oncology - Pediatrics

OFFICE ADDRESS:
MACC Fund Research Center
8701 Watertown Plank Rd
Milwaukee, WI 53226
Phone: 414-937-3841
Fax: 414-937-6284
Email: srrao@mcw.edu

EDUCATION:
09/1990 - 06/1994 BS - Chemical Engineering, University of Minnesota, MN
07/1994 - 06/2001 MD, University of Chicago, Chicago, IL
07/1996 - 06/1999 PhD - Pathology, University of Chicago, Chicago, IL

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/01/2001 - 06/30/2004 Resident, Pediatrics, Children's Hospital, Boston, Boston, MA
07/01/2004 - 06/30/2007 Clinical Fellow, Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA
07/01/2005 - 11/30/2010 Research Fellow, Pediatric Oncology, Laboratory of Dr. Stuart H. Orkin, Dana Farber Cancer Institute, Boston, MA

FACULTY APPOINTMENTS:
07/2007 - 11/2010 Instructor, Department of Pediatrics, Harvard Medical School, Cambridge, MA
12/2010 - Present Associate Investigator, Blood Research Institute, Stem Cell Biology Program, BloodCenter of Wisconsin, Milwaukee, WI
07/01/2011 - Present Assistant Professor, Cell Biology, Neurobiology, and Anatomy, MCW, Milwaukee, WI
08/01/2011 - Present Assistant Professor, Pediatrics, Hematology/Oncology/Transplantation, MCW, Milwaukee, WI

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
07/2007 - 11/2010 Attending, Pediatric Oncology, Division of Hematopoietic Stem Cell Transplantation, Dana Farber Cancer Institute, Boston, MA
07/2007 - 11/2010 Attending, Medicine, Division of Hematology/Oncology, Children’s Hospital, Boston, MA
07/01/2010 - Present Staff Physician, Pediatrics, Bone Marrow Transplantation, Children's Hospital of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
07/2007 - 11/2010 Inpatient Attending, Hematopoietic Stem Cell Transplantation, Children's Hospital, Boston, MA
07/2007 - 11/2010 Outpatient Attending, Hematopoietic Stem Cell Transplantation, Dana Farber Cancer Institute, Boston, MA
12/2010 - Present Inpatient Attending, Hematopoietic Stem Cell Transplantation, Children's Hospital of Wisconsin, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Certificates
Issued By Issue DateExpiration
General Pediatrics
American Board of Pediatrics
2004
2011
Pediatric Hematology/Oncology
American Board of Pediatrics
2009
2021
 

Licensure
Number Issue DateExpiration
Massachusetts Full Medical License
2005
None
Wisconsin Full Medical License
55842-20
06/01/2011
10/31/2021
 

AWARDS AND HONORS:
05/2001 AOA Membership, University of Chicago Pritzker School of Medicine
06/2001 Graduation with Honors, University of Chicago Pritzker School of Medicine
09/2011 Dr Richard Aster Award, Blood Research Institute, Milwaukee, WI

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2007 - Present American Society of Hematology (Member)
2007 - Present American Society of Blood and Marrow Transplantation (Member)
2010 - Present International Society of Stem Cell Research (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
Mol Cell Biology
Frontiers in Biology, Blood, Molecular and Cellular Biology
PLoS One
Stem Cells
Cell Reports
Nature Communications
Scientific Reports

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Epigenetic Reprogramming in Relapse AML
Source:
Bear Necessities Pediatric Cancer Foundation
Role:
co-Investigator
PI:
M. Burke
Dates:
07/01/2016 - 06/30/2017
Direct Funds:
$20,000 (Currently in a no-cost extension)
 
Title:
GATA4 in Development of a Normal Squamocolumnar Junction and Barrett’s Esophagus
Source:
NIH/NIDDK
Role:
co-Investigator
PI:
M. Battle
Dates:
07/01/2017 - 06/30/2019
Direct Funds:
$5,513
 
Title:
Cohesin Mutations in AML
Source:
NIH/NCI
Role:
PI
PI:
Rao
Dates:
08/22/2017 - 06/30/2022
Direct Funds:
$250,000
 
Prior
Peer Review
Title:
NICHD Child Health Research Scholar
Source:
Career Development Award, NIH/NICHD 5K12HD052896
Role:
Research Scholar
Dates:
07/2007 - 06/2008
 
Title:
Identification of Master Regulators for Early Lineage Commitment
Source:
Seed Grant, Harvard Stem Cell Institute
Role:
Co-Investigator
Dates:
07/2007 - 06/2009
Direct Funds:
$45,000 (The major goals of this project are to identify master regulators of early lineage commitment to the mesoderm and cardiac lineage using a genetic screen)
 
Title:
Exploring the Transcriptional Network Regulating ES cell Pluripotency
Source:
Career Development Award, NIH/NHLBI 5K08HL87951
Role:
Principal Investigator
PI:
Self
Dates:
07/2007 - 06/2012
Direct Funds:
$125,000 (The major goal of this project is to understand the transcriptional mechanisms used by mESC to maintain a pluripotent state utilizing multiple genome-wide techniques.)
 
Title:
Identifying shared transcriptional programs between leukemic and embryonic stem cells
Source:
MCW Cancer Center Pilot Grant
Role:
Principal Investigator
Dates:
07/2012 - 06/2013
Direct Funds:
$30,000 (The major goal of this project is to identify shared transcriptional programs between different types of normal and abnormal stem cells)
 
Title:
Leukemia Stem Cells in ALL
Source:
MACC Fund Novel Initiative Award
Role:
Principal Investigator
Dates:
09/2012 - 09/2013
Direct Funds:
$35,000 (The major goal of this project was to assess the role of Sall4 in development of ALL stem cells)
 
Title:
Leukemia: molecular and cellular mechanisms of pathogenesis and immunotherapy
Source:
Large Center Grant Pilot Funding for Cancer Research
Role:
Project Leader
Dates:
01/2013 - 12/2013
Direct Funds:
$31,000 (The major goal of this project is to assess the role of secondary mutations in the cohesion complex on AML pathogenesis)
 
Title:
Molecular Basis of Human Hepatic Progenitor Cell Formation
Source:
NIH/NIDDK
Role:
CO-Investigator
Dates:
07/2014 - 07/2016
Direct Funds:
$10,000 (Our contribution is solely computational biology support, specifically the analysis and integration of ChIP-seq and transcriptome datasets. )
 
Title:
The Role of Cohesin Proteins in Acute Myelogenous Leukemia
Source:
Hyundai Hope on Wheels
Role:
Principal Investigator
Dates:
01/2015 - 01/2017
Direct Funds:
$125,000
 
Title:
Role of Enhancer-Transcribed RNAs and Tet Proteins in Stem Cells
Source:
American Society of Hematology
Role:
Principal Investigator
Dates:
03/2015 - 03/2016
Direct Funds:
$150,000
 
Non-Peer Review
Title:
Role of Cohesin Mutations in Leukemia
Source:
Heartland Blood Center
Role:
co-PI
PI:
Rao and Crispino
Dates:
10/01/2015 - 09/30/2017
Direct Funds:
$100,000
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
The role of Sall4 isoforms in mESC pluripotency, Oral Presentation, Department of Pediatric Oncology, DFCI retreat, 2009
Identification of Master Regulators for Early Lineage Commitment, Oral Presentation, Harvard Stem Cell Institute retreat, 2009
 
Regional
S Rao, Cohesin Mutations in AML, Invited Departmental Seminar, IUPUI-South Bend/Notre Dame, 2016
S Rao, Cohesin Mutations in AML, Invited Departmental Seminar, Northwestern University, Dept. of Cell Biology, 2017
 
International
The role of Sall4 in Embryonic Stem Cell Pluripotency (Oral presentation of Abstract), ASBMT/CIMBTR tandem meetings, Orlando, FL, 2010
 

COMMITTEE SERVICE:
Medical College
01/01/2011 - Present Member, Medical Scientist Training Program Admissions Committee, MCW
09/01/2015 - 06/01/2017 Member, CBNA Search Committee
2016 - 2017 Member, Section Chief Search, Hematology, Oncology, and Transplantations, Pediatrics
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
2017 M2- One lecture "Tumor Immunology."
 
Graduate Student Education
2014 - 2016 Advanced Stem Cell Biology, Two Graduate Lectures
2015 - Present Molecular Techniques, One Lecture Each Year on RNA-seq
2017 - Present Advanced Cell Biology, Two Lectures
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
Jeremy Allred, MCW, 12/01/2010 - 2012 Primary Research Mentor, Current Position- Medicine Resident, Univ. of Minnesota
Jennifer Miksanek, MCW, 12/2012 - 2016 Primary Research Mentor, Current Position- Resident, University of Iowa
Emily Philips, MCW, 2015 - Present Primary Research Mentor, Current Position, MCW M3
Lauren Engel, MCW, 2016 - Present Primary Research Mentor
 
Graduate Students
PhD Committees
Jamie Karcher, MCW, 05/2012 - 02/2014 High Salt Diet Suppresses the Angiogenic Competency of Bone Marrow Mononuclear Cells in the Rat.
Cayla Lillge, MCW, 07/12/2012 - 2017 GATA4 Regulates Regionalization Along the Small Intestine Epithelium.
Amanda Urick, MCW, 04/2013 - 2017
Dan Schill, MCW, 07/2014 - Present
Matt Waas, MCW, 07/2014 - Present
Michael Flinn, MCW, 07/2014 - Present
David Schauder, MCW, 2014 - Present
Kathleen Dixon, MCW, 2015 - Present
Cheng-Yin Yuan, MCW, 2015 - Present
Emily Gronseth, MCW, 2015 - Present
Joshua Nord, MCW, 2015 - Present
Timothy Stodola, MCW, 2017 - Present
Tiffany Claeys, MCW, 2017 - Present
Kathryn Hendee, MCW
PhD Students Advised
Michael Reimer, MCW, 06/2013 - Present
Steven Blinka, MCW, 06/2013 - 2017 Transcribed cis-Regulatory Elements Differentially Regulate Neighboring Genes at the Nanog Locus, Current Position- MCW, M3
Katelyn Heimbruch, MCW, 2017 - Present
Puja Agarwal, MCW, 2017 - Present
 
Clinical/Research Fellows
Samuel Milanovich, MCW, 07/2011 - 07/2014 Primary Research Mentor, Current Position, Lab Based Physician Scientist, Sanford Research Institute, South Dakota
Jonathan Roberts, MD, MCW, 06/2012 - 07/2014 Scholarship Committee
Lauren Pommert, MCW, 2017 - Present Primary Research Mentor
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Graduate Students
PhD Committees
Maureen McNulty, Northwestern University, 2015 - Present
 
Clinical/Research Fellows
Joseph Fisher, Blood Research Institute, 2015 - 2017 Primary, Currently- Faculty at Concordia University
 

AD HOC REVIEWER:
06/2012 Dev2 Study Section (NIH)
02/2013 Dev2 Study Section (NIH)
11/2013 Dev2 Study Section (NIH)
11/2013 SEP-PAR13-095(NIH)
02/2014 SEP-PAR13-095(NIH)
02/2015 SEP-PAR13-095(NIH)
2016 Leukemia Research Foundation
2016 NYSTEM reviewer
2017 Dev2 Study Section

THESIS:
The Role of PU.1 and Spi-B in B-lymphocyte Function


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Sielaff, T., Hu, M., Rao, S., Groehler, K., Olson, D., Mann, H., Remmel, R., Shatford, R., Amiot, B., Bloomer, J., Hu, W., and Cerra, F. (1995). Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J. of Surgical Research 59, 179-184.
2. Sielaff, T., Hu, M., Rao, S., Groehler, K., Olson, D., Mann, H., Remmel, R., Shatford, R., Amiot, B., Hu, W., and Cerra, F. (1995). A technique for porcine hepatocyte harvest and description of differentiated metabolic functions in static culture. Transplantation 59, 1459-1463
3. Garrett-Sinha, L., Su, G.H., Rao, S., Kabak, S., Hao, Z., Clark, M.R., and Simon, M.C. (1999). PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. Immunity 10, 399-408
4. Rao, S., Garrett-Sinha, L., Yoon, J., and Simon, M. C. (1999). The Ets factors PU.1 and Spi-B regulate the transcription in vivo of P2Y10, a lymphoid restricted heptahelical receptor. J Biol Chem 274, 34245-52.
5. Rao, S., Matsumura, A., Yoon, J., and Simon, M. C. (1999). SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1. J Biol Chem 274, 11115-24.
6. Garrett-Sinha, L.A, Dahl, R., Rao, S., and Simon, M.C. (2001) PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1. Blood 97, 2908-2912.
7. Hu, C.J., Rao, S., Ramirez-Bergeron, D.L., Gerondakis, S., and Simon, M.C. (2001) PU.1/Spi-B regulation of c-rel¬ is essential for mature B cell survival. Immunity 15, 545-555
8. Dahl, R., Ramirez-Bergeron, D.L., Rao, S., and Simon, M.C. (2002) Spi-B can functionally replace PU.1 in myeloid but not lymphoid development. EMBO J 21, 2220-2230
9. Garrett-Sinha, L.A., Hou, P., Wang, D., Grabiner, B., Araujo, E., Rao, S. , Yun, T.J., Clark, E.A., Simon, M.C., Clark, M.R. (2005) Spi-1 and Spi-B control the expression of the Grap2 gene in B cells. Gene 20,134-146
10. Wang, J., Rao, S., Chu, J., Shen, X., Levasseur, D., Theunissen, T., Orkin, S.H.(2006) A protein interaction network for pluripotency of embryonic stem cells. Nature 44, 364-368
11. Rao, S., Shao, Z., Roumiantsev, S., McDonald, L., Yuan, G., Orkin, S.H. (2010) Differential Roles of Sall4 Isoforms in Embryonic Stem Cell Pluripotency. MCB 30, 5364-80
12. Koh, K., Yabuuchi, A., Rao, S., Huang, Y., Cunniff, K., Nardone, J., Laiho, A., Tahiliani, M., Sommer, C.A., Mostoslavsky, G., Lahesmaa, R., Orkin, S.H., Rodig, S.J., Daley, G.Q., Rao, A. (2011) Tet1 and Tet2 regulate 5-hydroxymethlcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell, 8, 200-213.
13. Gundry RL, Riordon DR, Tarasova Y, Chuppa S, Bhattacharya S, Juhasz O, Wiedemeier O, Milanovich S, Noto FK, Tchernyshyov I, Raginski K, Bausch-Fluck D, Tae HJ, Marshall S, Duncan SA, Wollscheid B, Wersto RP, Rao S, Van Eyk JE, Boheler KR. A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells. Mol Cell Proteomics. 2012 Aug;11(8):303-16. PMCID: PMC3412963
14. Pulakanti K, Pinello L, Stelloh C, Blinka S, Allred J, Milanovich S, Kiblawi S, Peterson J, Wang A, Yuan GC, Rao S. Enhancer transcribed RNAs arise from hypomethylated, Tet-occupied genomic regions. Epigenetics. 2013 Dec;8(12):1303-20. PMCID: PMC3933491
15. Boheler KR, Bhattacharya S, Kropp EM, Chuppa S, Riordon DR, Bausch-Fluck D, Burridge PW, Wu JC, Wersto RP, Chan GC, Rao S, Wollscheid B, Gundry RL. A human pluripotent stem cell surface N-glycoproteome resource reveals markers, extracellular epitopes, and drug targets. Stem Cell Reports. 2014 Jul 08;3(1):185-203. PMCID: PMC4110789
16. Milanovich S, Peterson J, Allred J, Stelloh C, Rajasekaran K, Fisher J, Duncan SA, Malarkannan S, Rao S. Sall4 overexpression blocks murine hematopoiesis in a dose-dependent manner. Exp Hematol. 2015 Jan;43(1):53-64.e1-8. PMCID: PMC4268405
17. Sohni A, Bartoccetti M, Khoueiry R, Spans L, Vande Velde J, De Troyer L, Pulakanti K, Claessens F, Rao S, Koh KP. Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation. Mol Cell Biol. 2015 Mar;35(6):1026-42
18. Stelloh C, Reimer MH, Pulakanti K, Blinka S, Peterson J, Pinello L, Jia S, Roumiantsev S, Hessner MJ, Milanovich S, Yuan GC, Rao S. The cohesin-associated protein Wapal is required for proper Polycomb-mediated gene silencing. Epigenetics Chromatin. 2016;9:14. PMCID: PMC4832553
19. Swartz KL, Wood SN, Murthy T, Ramirez O, Qin G, Pillai MM, Rao S, Minella AC. E2F-2 Promotes Nuclear Condensation and Enucleation of Terminally Differentiated Erythroblasts. Mol Cell Biol. 2017 01 01;37(1). PMCID: PMC5192079
20. Thompson CA, Wojta K, Pulakanti K, Rao S, Dawson P, Battle MA. GATA4 Is Sufficient to Establish Jejunal Versus Ileal Identity in the Small Intestine. Cell Mol Gastroenterol Hepatol. 2017 May;3(3):422-446. PMCID: PMC5404030
21. Zhang N, Zhi H, Curtis BR, Rao S, Jobaliya C, Poncz M, French DL, Newman PJ. CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes. Blood. 2016 Feb 11;127(6):675-80. PMCID: PMC4751021
22. Blinka S, Reimer MH Jr, Pulakanti K, Rao S. Super-Enhancers at the Nanog Locus Differentially Regulate Neighboring Pluripotency-Associated Genes. Cell Rep. 2016 09 27;17(1):19-28. PMCID: PMC5111363
23. Fisher JB, Peterson J, Reimer M, Stelloh C, Pulakanti K, Gerbec ZJ, Abel AM, Strouse JM, Strouse C, McNulty M, Malarkannan S, Crispino JD, Milanovich S, Rao S. The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of Hoxa7 and Hoxa9. Leukemia. 2017 03;31(3):712-719. PMCID: PMC5332284
24. Fisher JB, Pulakanti K, Rao S, Duncan SA. GATA6 is essential for endoderm formation from human pluripotent stem cells. Biol Open. 2017 Jul 15;6(7):1084-1095. PMCID: PMC5550920
25. Jing W, Gershan JA, Holzhauer S, Weber J, Palen K, McOlash L, Pulakanti K, Wesley E, Rao S, Johnson BD, Riese MJ. T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia. Cancer Res. 2017 10 15;77(20):5676-5686.
26. Blinka S, Rao S. Nanog Expression in Embryonic Stem Cells - An Ideal Model System to Dissect Enhancer Function. Bioessays. 2017 Dec;39(12). PMCID: PMC5878941
27. Meyer AE, Rao S, Fisher JB. Cohesin mutations: contributors to myeloid malignancies. Oncotarget. 2017 Oct 06;8(46):80107-80108. PMCID: PMC5655182
28. Broglie L, Pommert L, Rao S, Thakar M, Phelan R, Margolis D, Talano J. Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis. Blood Adv. 2017 Aug 22;1(19):1533-1536. PMCID: PMC5728466
29. Nanbakhsh A, Best B, Riese M, Rao S, Wang L, Medin J, Thakar MS, Malarkannan S. Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells. J Vis Exp. 2018 01 15(131). PMCID: PMC5908645
30. Newman DK, Fu G, McOlash L, Schauder D, Newman PJ, Cui W, Rao S, Johnson BD, Gershan JA, Riese MJ. Frontline Science: PECAM-1 (CD31) expression in naïve and memory, but not acutely activated, CD8 T cells. J Leukoc Biol. 2018 11;104(5):883-893. PMCID: PMC6195461
31. Volk A, Liang K, Suraneni P, Li X, Zhao J, Bulic M, Marshall S, Pulakanti K, Malinge S, Taub J, Ge Y, Rao S, Bartom E, Shilatifard A, Crispino JD. A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis. Cancer Cell. 2018 11 12;34(5):707-723.e7. PMCID: PMC6235627
32. Stoltz KP, Jondle CN, Pulakanti K, Sylvester PA, Urrutia R, Rao S, Tarakanova VL. Tumor suppressor Interferon Regulatory Factor 1 selectively blocks expression of endogenous retrovirus. Virology. 2019 01 02;526:52-60.
33. Gupta AK, Murthy T, Paul KV, Ramirez O, Fisher JB, Rao S, Rosenberg AB, Seelig G, Minella AC, Pillai MM. Degenerate minigene library analysis enables identification of altered branch point utilization by mutant splicing factor 3B1 (SF3B1). Nucleic Acids Res. 2019 01 25;47(2):970-980. PMCID: PMC6344872
34. Agrawal P, Heimbruch KE, Rao S. Genome-Wide Maps of Transcription Regulatory Elements and Transcription Enhancers in Development and Disease. Compr Physiol. 2018 12 13;9(1):439-455. PMCID: PMC6566905
35. DeLaForest A, Di Furio F, Jing R, Ludwig-Kubinski A, Twaroski K, Urick A, Pulakanti K, Rao S, Duncan SA. HNF4A Regulates the Formation of Hepatic Progenitor Cells from Human iPSC-Derived Endoderm by Facilitating Efficient Recruitment of RNA Pol II. Genes (Basel). 2018 Dec 28;10(1). PMCID: PMC6356828
36. Ray A, Khalil MI, Pulakanti KL, Burns RT, Gurski CJ, Basu S, Wang D, Rao S, Dittel BN. Mature IgD B cells maintain tolerance by promoting regulatory T cell homeostasis. Nat Commun. 2019 01 14;10(1):190. PMCID: PMC6331566
37. Tang J, Zhu N, Rao S, Carlson KS. Stem cell damage after chemotherapy- can we do better? Best Pract Res Clin Haematol. 2019 03;32(1):31-39.
38. Izaguirre-Carbonell J, Christiansen L, Burns R, Schmitz J, Li C, Mokry RL, Bluemn T, Zheng Y, Shen J, Carlson KS, Rao S, Wang D, Zhu N. Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia. Blood Adv. 2019 May 14;3(9):1499-1511. PMCID: PMC6517669
39. Reimer M Jr, Pulakanti K, Shi L, Abel A, Liang M, Malarkannan S, Rao S. Deletion of Tet proteins results in quantitative disparities during ESC differentiation partially attributable to alterations in gene expression. BMC Dev Biol. 2019 07 08;19(1):16. PMCID: PMC6615237
40. Yang C, Siebert JR, Burns R, Gerbec ZJ, Bonacci B, Rymaszewski A, Rau M, Riese MJ, Rao S, Carlson KS, Routes JM, Verbsky JW, Thakar MS, Malarkannan S. Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. Nat Commun. 2019 Sep 02;10(1):3931. PMCID: PMC6718415
41. Gao C, Schroeder JA, Xue F, Jing W, Cai Y, Scheck A, Subramaniam S, Rao S, Weiler H, Czechowicz A, Shi Q. Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice. Blood Adv. 2019 Sep 24;3(18):2700-2711. PMCID: PMC6759737
42. Nanbakhsh A, Srinivasamani A, Holzhauer S, Riese MJ, Zheng Y, Wang D, Burns R, Reimer MH, Rao S, Lemke A, Tsaih SW, Flister MJ, Lao S, Dahl R, Thakar MS, Malarkannan S. Disrupts Inflammatory but Not Cytotoxic Responses of NK Cells. Cancer Immunol Res. 2019 Oct;7(10):1647-1662.
 
Books, Chapters, and Reviews
1. Rao, S., and Simon, M. C. (2000). The role of PU.1 in B-lymphocyte development and function. In: Transcriptional regulation in normal and malignant hematopoiesis, J. Licht and K. Ravid, eds. (Boston: McGraw-Hill).
2. Rao, S., Orkin, S.H., (2006) Unraveling the transcriptional network controlling ES cell pluripotency. Genome Biology 7, 230
3. Orkin, S. H. Wang, J., Kim, J., Chu, J., Rao, S., Theunissen, T.W., Shen, X., and Levasseur, D.N. in Cold Spring Harbor Symposia on Quantitative Biology Vol. LXXIII (Cold Spring Harbor Laboratory Press, Cold Spring Harbor Laboratory 2008)
4. Wang, J., Trowbridge, J. J., Rao, S. & Orkin, S. H. Vol. StemBook.1.4.1 (eds B. E. Bernstein & I. Lemischka) (stembook.org, 2008).
5. Rao S. Embryonic Stem Cells: A Perfect Tool for Studying Mammalian Transcriptional Enhancers. J Stem Cell Res Ther. 2012 Jul 05;Suppl 10. PMCID: PMC3844140
6. Abel AM, Schuldt KM, Rajasekaran K, Hwang D, Riese MJ, Rao S, Thakar MS, Malarkannan S. IQGAP1: insights into the function of a molecular puppeteer. Mol Immunol. 2015 Jun;65(2):336-49. PMCID: PMC4480615
7. Rajasekaran K, Riese MJ, Rao S, Wang L, Thakar MS, Sentman CL, Malarkannan S. Signaling in Effector Lymphocytes: Insights toward Safer Immunotherapy. Front Immunol. 2016;7:176. PMCID: PMC4863891
8. Blinka S, Reimer MH Jr, Pulakanti K, Pinello L, Yuan GC, Rao S. Identification of Transcribed Enhancers by Genome-Wide Chromatin Immunoprecipitation Sequencing. Methods Mol Biol. 2017;1468:91-109. PMCID: PMC5111358
9. Fisher JB, McNulty M, Burke MJ, Crispino JD, Rao S. Cohesin Mutations in Myeloid Malignancies. Trends Cancer. 2017 04;3(4):282-293. PMCID: PMC5472227
10. Blinka S and S Rao. Nanog Expression in Embryonic Stem Cells-an Ideal Model System to Dissect Enhancer Function BioEssays. .
 
Editorials, Letters to Editor, Other
1. A Meyer, S Rao, J Fisher. Cohesin mutations: contributors to myeloid malignancies Oncotarget. .
 

jenkins-FCD Prod-406 0f9a74600e4e79798f8fa6f545ea115f3dd948b2